Michelle Shiller, DO

Michelle Shiller, DO, is a molecular genetic pathologist at Baylor University Medical Center

Articles by Michelle Shiller, DO

Ronan J. Kelly, MD, MBA, FASCO, director, Charles A. Sammons Cancer Center, chief science officer, Baylor University Medical Center, W.W. Caruth Jr. Endowed Chair of Immunology, Baylor University Medical Center, chief, Oncology, Baylor Scott & White Health System, founder and medical director, Texas Cancer Interception Institute, clinical professor, Texas A&M University College of Medicine, adjunct associate professor, oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, professor, Clinical Sciences Division, Translational Genomics Research Institute; Michelle Shiller, DO, AP/CP, MGP, molecular genetic pathologist, Baylor University Medical Center

Multidisciplinary Collaboration Gives Forward Momentum to HER2 IHC Testing in NSCLC: With Ronan J. Kelly, MD, MBA, FASCO; and Michelle Shiller, DO, AP/CP, MGP

ByRonan J. Kelly, MD, MBA, FASCO,Michelle Shiller, DO

August 19th 2025

Drs Kelly and Shiller discuss the importance of performing IHC testing for HER2 in NSCLC and recommendations for IHC testing implementation in practice.

Martin F. Dietrich, MD, PhD, medical oncologist, Cancer Care Centers of Brevard, The US Oncology Network, assistant professor, internal medicine, the University of Central Florida College of Medicine; Michelle Shiller, DO, cancer liaison physician, medical director, Genetics, assistant medical director, Baylor Scott & White Health in Dallas, medical director, Genomics and Molecular Pathology Services, PathGroup

Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing

ByMartin Dietrich, MD, PhD,Michelle Shiller, DO

June 27th 2024

Drs Dietrich and Shiller detail the importance of collaboration between medical oncologists and pathologists to ensure beneficial oncology reflex testing.

Michelle Shiller, DO

Articles by Michelle Shiller, DO

Multidisciplinary Collaboration Gives Forward Momentum to HER2 IHC Testing in NSCLC: With Ronan J. Kelly, MD, MBA, FASCO; and Michelle Shiller, DO, AP/CP, MGP

Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies